Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced that its MyoVista wavECG has been selected by PanaceaFlo Ltd to be used in Dublin, Ireland in its heart screening evaluation study

News | Artificial Intelligence

HeartSciences’ MyoVista wavECG Selected to be used in Irish Heart Screening Evaluation

August 24, 2023 —Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical ...

August 24, 2023

Giant in the field of cardiac electrophysiology remembered by colleagues and friends at UH Harrington Heart & Vascular Institute

Feature | Cardiovascular Business

Albert L. Waldo, MD, Has Passed Away After Brief Illness

August 22, 2023 — Leaders at University Hospitals (UH) Harrington Heart & Vascular Institute are saddened to share news ...

August 22, 2023

AI enhancing Cedars-Sinai patient care, clinical and research initiatives, and medical discoveries

News | Artificial Intelligence

Cedars-Sinai Charts Healthcare’s Future With Artificial Intelligence

August 17, 2023 — Artificial intelligence (AI) is capturing the public imagination as the pace of innovation accelerates ...

August 18, 2023

News | AHA

Study Links Pain After Heart Attack to Mortality Predictability

August 16, 2023 —Moderate or extreme pain after a heart attack – most commonly pain due to other health conditions – may ...

August 16, 2023

Clario and AliveCor provide a new trial participant-friendly solution for cutting-edge, at-home data collection with privacy protection, instrumental in situations where traditional 12-lead ECG cannot be collected.

News | ECG

Clario and AliveCor Collaborate to Offer Advanced, Trial- focused Six-lead ECG Solutions for Monitoring in Decentralized Clinical Trials

August 15, 2023 — Clario, a healthcare research technology company that delivers leading endpoint technology solutions ...

August 15, 2023

E-cigarettes likely not healthier alternative to traditional cigarettes

News | Stroke

New Evidence Bolsters Theory E-cigarettes May Increase Stroke Risk

August 15, 2023 — There is new evidence that bolsters a possible link between e-cigarette use and increased risk of ...

August 15, 2023

Esperion announced two oral presentations to take place in the Late-Breaking Science Session entitled “Clinical trial updates on prevention and lipid lowering” at the 2023 ESC Congress

News | Cardiovascular Clinical Studies

Two CLEAR Outcomes Study Late-Breakers Accepted at European Society of Cardiology (ESC) Congress 2023

August 14, 2023 — Esperion announced two oral presentations to take place in the Late-Breaking Science Session entitled ...

August 14, 2023

African Americans have higher average Lp(a) levels and are more likely to have heart disease than non-Hispanic whites, but there is not enough information on Lp(a) and cardiovascular disease risk in this population.

News | Cardiovascular Clinical Studies

Heart Study’s Goal: Better Understand and Serve the Underrepresented

August 10, 2023 — Cardiovascular disease is the number one killer of all Americans. Yet, African Americans are 30% more ...

August 10, 2023

Game-changing potential for drug testing and cardiovascular disease treatments - Tiny Heart Model carries massive implications

News | Cardiovascular Clinical Studies

Tiny, Multichambered Human Heart Model Developed by Hebrew University Researchers Could Transform Cardiovascular Research and Drug Evaluation

August 9, 2023 — A team of researchers, led by the Hebrew University of Jerusalem (HU), has developed a tiny human heart ...

August 09, 2023

Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial

News | Cardiovascular Clinical Studies

Major Adverse Cardiovascular Events Reduced in Overweight/Obese Patients with Wegovy, per SELECT Trial

August 9, 2023 — Novo Nordisk announced the headline results from the SELECT cardiovascular outcomes trial. The double ...

August 09, 2023

Although at greater risk, a new study found that patients of African ancestry with dilated cardiomyopathy (DCM) were less likely to have clinically actionable variants in DCM genes than those of European ancestry.

News | Cardiovascular Clinical Studies

Study Reveals Significant Difference in Cardiomyopathy Genes Between Black and White Patients

August 8, 2023 — Although at greater risk, a new study found that patients of African ancestry with dilated ...

August 08, 2023

The medication, known as a “polypill,” includes three active ingredients (acetylsalicylic acid, ramipril, and atorvastatin)

News | Nuclear Imaging

World Health Organization Includes the Cardiovascular Polypill in its list of Essential Medicines after a Groundbreaking Study Led by the President of Mount Sinai Heart

August 3, 2023 — The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC ...

August 03, 2023

Merit’s WAVE study is a prospective, randomized, controlled, multicenter study

News | Cardiovascular Clinical Studies

Merit Medical’s WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

August 3, 2023 — Merit Medical Systems, a leading global manufacturer and marketer of healthcare technology, today ...

August 03, 2023

India clinical trial commences with first 30 cases

News | Heart Valve Technology

First Patients Outside of U.S. Treated with TRIA Polymer Surgical Mitral Heart Valve

August 2, 2023 — Foldax , Inc., a leader in the development of innovative, polymer heart valves, today announced that ...

August 02, 2023

LX2020 preclinical studies demonstrated proof-of-concept with treatment restoring desmosomal integrity, reducing arrhythmias, and extending survival in a clinically relevant murine model

News | Pharmaceuticals

LEXEO Therapeutics Announces FDA Clearance of IND for LX2020, an AAV-based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy

August 1, 2023 —LEXEO Therapeutics, a clinical-stage gene therapy company advancing adeno-associated virus (AAV)-based ...

August 01, 2023